OTC : AOBI

American Oriental Bioengineering, Inc.

$0.0012 USD

$0 (0.0%)

Volume
1.01K
Average Volume
901
Market Capitalization
$88
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$0.00
Year Low
$0.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.90
Company Overview

OTC

Shujun Liu

Biotechnology

Healthcare

AOBI

3719

CN

USD

http://www.bioaobo.com

86 10 5982 2039

028731503

N/A

Liquidity Metrics

0.21

0.90

0.70

0.07

0.00

Sales & Valuation

$145.1M

0.00

0.00

0.00

-949.60

Profitability

-$781.24

-$59.71M

-41.15%

-39.63%

-16.84%

-13.38%

P/E Metrics

0.00

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

-0.46

3/9

-$61.54M

$427.62M

$143.95M

-$83.37M

Key Metrics (TTM)

$60.55M

0.42

-1.53

0.90

-16.84%

-13.88%

-65090234.45%

-82495293.18%

161 days

Company Executives
Name Title
Jun Min Founder, Vice President, General Manager of HSPL and Director
Shujun Liu Founder, Chairman, Chief Executive Officer and President
Xiaopeng Xu Chief Operating Officer
Yan Gao Chief Accounting Officer
Yongxin Zhou Director of Sales
Ziyun Zhou General Manager of Human Resources
Yanchun Li Founder, Chief Financial Officer, Secretary and Director
Poll Results

No votes yet today — be the first to share your view!

About American Oriental Bioengineering, Inc. (OTC:AOBI) Stock

American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feat ... ure the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.

Frequently Asked Questions

What is the current American Oriental Bioengineering, Inc. (AOBI) stock price?

American Oriental Bioengineering, Inc.(OTC:AOBI) stock price is $0.0012 in the last trading session. During the trading session, AOBI stock reached the peak price of $0.0012 while $0.0005 was the lowest point it dropped to. The percentage change in AOBI stock occurred in the recent session was 0.0% while the dollar amount for the price change in AOBI stock was $0.

AOBI's industry and sector of operation?

The OTC listed AOBI is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of AOBI?

Jun Min | Founder, Vice President, General Manager of HSPL and Director
Shujun Liu | Founder, Chairman, Chief Executive Officer and President
Xiaopeng Xu | Chief Operating Officer
Yan Gao | Chief Accounting Officer
Yongxin Zhou | Director of Sales

How many employees does AOBI have?

Number of AOBI employees currently stands at 3719. AOBI operates from 1 First Liangshuihe Avenue, Beijing, BE 100176, CN.

Link for AOBI official website?

Official Website of AOBI is: http://www.bioaobo.com

How do I contact AOBI?

AOBI could be contacted at phone #86 10 5982 2039 and can also be accessed through its website. AOBI operates from 1 First Liangshuihe Avenue, Beijing, BE 100176, CN.

How many shares of AOBI are traded daily?

The average number of AOBI shares traded daily for last 3 months was 901.

What is the market cap of AOBI currently?

The market value of AOBI currently stands at $88 with its latest stock price at $0.0012